Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their written agreement to take part in the study
- People who are receiving a specific type of knee replacement called a GEMINI SL Fixed Bearing PS knee prosthesis
- People between 18 and 80 years of age
Who may not be able to join:
- People with a Body Mass Index (BMI) over 40 kg/m² (a measure of body weight relative to height)
- People whose life expectancy is expected to be less than 5 years
- People who have other health conditions or circumstances that are likely to affect how well their knee replacement works or heals — for example, neurological conditions or other bone and muscle diseases (confirm with trial site)
- People who are not able to understand what the study involves due to cognitive or mental health reasons
- People who are unlikely to be able to attend the planned check-ups and follow-up visits required by the study
- People who are currently in prison
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julio Cesar Palacio Villegas, Dr., Centro Medico Imbanaco Sede Principal
Phone: +49 (0)40 53995866
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
10-year survival rate of the Gemini SL Fixed Bearing PS knee prothesis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.